Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dewi Vernerey

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2020
How to Choose the Right Treatment for Patients With Advanced Squamous Cell Carcinoma in the Absence of a Comparative Randomized Clinical TrialStefano Kim, Dewi Vernerey, Christophe Borg
The British Journal of Dermatology|March 4, 2025
Ipilimumab + nivolumab in combination vs. nivolumab monotherapy as first-line treatment in patients with metastatic melanoma: conclusions from a real-world French national cohortCharlée Nardin, Dewi Vernerey, François Aubin
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 15, 2026
Surgical modality non-inferiority testing with an intensification of adjuvant treatments: a missed opportunityFabrice R Lecuru, Davide Cibula, Dewi Vernerey
Journal of Cardiac Surgery|February 4, 2015
Early detection of asymptomatic bypass graft abnormalities using a cardiac troponin I ratio following coronary artery bypass surgeryAndrea Perrotti, Paul Luporsi, Camille Durst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2025
Reply to: Random Assignment, But Without Comparison: A Missed OpportunityDewi Vernerey, Jean-Baptiste Bachet, Antonio Sa Cunha, et al.
Lancet (London, England)|January 17, 2026
Interpreting the pT1 subgroup in the ASTER 70s trial - Authors' replyEtienne Brain, Florence Rollot-Trad, Telma Roques, et al.
Clinics and Research in Hepatology and Gastroenterology|August 21, 2022
Correlation between efficacy endpoints in patients with advanced biliary tract cancer treated by systemic second-line therapies: Analysis of aggregated data from a systematic literature reviewCindy Neuzillet, David Malka, Astrid Lièvre, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 26, 2018
Peritoneal dialysis after kidney transplant failure: a nationwide matched cohort study from the French Language Peritoneal Dialysis Registry (RDPLF)Myriam Benomar, Clement Vachey, Thierry Lobbedez, et al.
Scientific Reports|June 1, 2024
Interaction analysis of subgroup effects in randomized trials: the essential methodological pointsAbraham Fingerhut, Selman Uranues, Chadly Dziri, et al.
Cancers|November 13, 2021
Impact of Immunoscore on the Management of Stage II Colon Cancer Patients: A Physician SurveyAnup Kasi, Efrat Dotan, Graham M Poage, et al.
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2020
How to Choose the Right Treatment for Patients With Advanced Squamous Cell Carcinoma in the Absence of a Comparative Randomized Clinical TrialStefano Kim, Dewi Vernerey, Christophe Borg
The British Journal of Dermatology|March 4, 2025
Ipilimumab + nivolumab in combination vs. nivolumab monotherapy as first-line treatment in patients with metastatic melanoma: conclusions from a real-world French national cohortCharlée Nardin, Dewi Vernerey, François Aubin
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 15, 2026
Surgical modality non-inferiority testing with an intensification of adjuvant treatments: a missed opportunityFabrice R Lecuru, Davide Cibula, Dewi Vernerey
Journal of Cardiac Surgery|February 4, 2015
Early detection of asymptomatic bypass graft abnormalities using a cardiac troponin I ratio following coronary artery bypass surgeryAndrea Perrotti, Paul Luporsi, Camille Durst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2025
Reply to: Random Assignment, But Without Comparison: A Missed OpportunityDewi Vernerey, Jean-Baptiste Bachet, Antonio Sa Cunha, et al.
Lancet (London, England)|January 17, 2026
Interpreting the pT1 subgroup in the ASTER 70s trial - Authors' replyEtienne Brain, Florence Rollot-Trad, Telma Roques, et al.
Clinics and Research in Hepatology and Gastroenterology|August 21, 2022
Correlation between efficacy endpoints in patients with advanced biliary tract cancer treated by systemic second-line therapies: Analysis of aggregated data from a systematic literature reviewCindy Neuzillet, David Malka, Astrid Lièvre, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 26, 2018
Peritoneal dialysis after kidney transplant failure: a nationwide matched cohort study from the French Language Peritoneal Dialysis Registry (RDPLF)Myriam Benomar, Clement Vachey, Thierry Lobbedez, et al.
Scientific Reports|June 1, 2024
Interaction analysis of subgroup effects in randomized trials: the essential methodological pointsAbraham Fingerhut, Selman Uranues, Chadly Dziri, et al.
Cancers|November 13, 2021
Impact of Immunoscore on the Management of Stage II Colon Cancer Patients: A Physician SurveyAnup Kasi, Efrat Dotan, Graham M Poage, et al.
Pageof 16